WHO ICTRP trial
Efficaay of microneedling plus mixed growth factors solutions derived from human…
ChiCTR1800014246 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800014246 |
|---|---|
| Public title | Efficaay of microneedling plus mixed growth factors solutions derived from human mesenchymal stem cell for chloasma |
| Scientific title | Efficacy of microneedling plus mixed growth factors solutions derived from human mesenchymal stem cell for chloasma: a Randomized, Controlled, Blinded Split-Fcae Study |
| Primary sponsor | Beijing Friendship Hospital affiliated to Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Chloasma |
| Interventions | Two groups:microneedling versus microneedling plus mixed growth factors solutions |
| Registration date | Jan 1, 2018 |
| Target size | Two groups:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: